New attack on deadly pancreatic cancer spread

NCT ID NCT07333287

Summary

This study is testing a new combination treatment for people with pancreatic cancer that has spread to the liver and who have not had prior treatment. The approach delivers chemotherapy directly to the liver tumors and combines it with two immunotherapy drugs. The main goal is to see if this combination can slow or stop the cancer from growing.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER LIVER METASTASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.